Onchocerciasis (river blindness): larva‐induced eczema (onchodermatitis) from an important oculocutaneous tropical disease spilling over into North America and Europe

Flubendazole as a macrofilaricide: History and background

(2019) Timothy G. Geary et al.   PLoS Neglected Tropical Diseases

Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys

(2019) Joseph Nelson Siewe Fodjo et al.   Infectious Diseases of Poverty

High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment

(2019) Deby Mukendi et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Economic evaluations of onchocerciasis interventions: a systematic review and research needs

(2019) Hugo C. Turner et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial

(2018) Nicholas O Opoku et al.   LANCET

Efficacy and tolerability of moxidectin alone and in co-administration with albendazole and tribendimidine versus albendazole plus oxantel pamoate against Trichuris trichiura infections: a randomised, non-inferiority, single-blind trial

(2018) Beatrice Barda et al.   LANCET INFECTIOUS DISEASES

Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world

(2018) Rubén Santiago Nicholls et al.   Parasites & Vectors

Alternative treatment strategies to accelerate the elimination of onchocerciasis

(2018) Michel Boussinesq et al.   International Health

Onchocerciasis in Yemen: moving forward towards an elimination program

(2018) Abdul-Samid Al-Kubati et al.   International Health

Report of the first international workshop on onchocerciasis-associated epilepsy

(2018) Robert Colebunders et al.   Infectious Diseases of Poverty

High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo

(2018) Evy Lenaerts et al.   Infectious Diseases of Poverty

Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes

(2018) Yankum Dadzie et al.   Infectious Diseases of Poverty

A Serological Survey of Human Onchocerciasis in Yemen

(2018) Charles D. Mackenzie et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Noninvasive Urine Biomarker Lateral Flow Immunoassay for Monitoring Active Onchocerciasis

(2018) Ryan J. Shirey et al.   ACS Infectious Diseases

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin

(2018) Joseph Nelson Siewe Fodjo et al.   Infectious Diseases of Poverty

Imported filariasis in Europe: A series of 31 cases from Metropolitan France

(2017) M. Develoux et al.   European Journal of Internal Medicine

Is imported onchocerciasis a truly rare entity? Case report and review of the literature

(2017) Spinello Antinori et al.   Travel Medicine and Infectious Disease

Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity

(2017) Stephen R. Doyle et al.   PLoS Neglected Tropical Diseases

Detection of Onchocerca volvulus in Skin Snips by Microscopy and Real-Time Polymerase Chain Reaction: Implications for Monitoring and Evaluation Activities

(2016) Elizabeth A. Thiele et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Diagnostic Tools for Onchocerciasis Elimination Programs

(2015) Johnny Vlaminck et al.   TRENDS IN PARASITOLOGY

History of Avermectin and Ivermectin, with Notes on the History of Other Macrocyclic Lactone Antiparasitic Agents

(2012) William C. Campbell   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Onchocerciasis: the Role of Wolbachia Bacterial Endosymbionts in Parasite Biology, Disease Pathogenesis, and Treatment

(2011) F. Tamarozzi et al.   CLINICAL MICROBIOLOGY REVIEWS